Upcoming trends in hematological malignancies
Oncology experts from leading cancer organizations from around the country, including the John Theurer Cancer Center, MD Anderson Cancer Center, the Mayo Clinic, Dana Farber Cancer Institute and the National Cancer Institute, will discuss trends in patient care, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies. Key topics include chronic lymphocytic leukemia, the role of molecular biomarkers in diffuse large b-cell lymphoma, follicular lymphoma, management of multiple myeloma and immunomodulation and hematopoietic stem cell transplant.
Featured Speakers:
- Andre Goy, M.D. - Deputy Director, John Theurer Cancer Center, Chief, Division of Lymphoma; Director, Cancer Research
- Susan O'Brien, M.D. - MD Anderson Cancer Center; Professor, Department of Leukemia, Division of Cancer Medicine
- Wyndham Wilson, M.D., Ph.D. - National Cancer Institute, Chief, Lymphoma Therapeutics, Metabolic Branch, Center for Cancer Research
- Carol Portlock, M.D. - Memorial Sloane-Kettering Cancer Center, Professor of Medicine, Attending Physician of Lymphoma
- Rafael Fonseca, M.D. - Mayo Clinic, Professor of Medicine, Deputy Director of Mayo Clinic Cancer Center
- Robert J. Soiffer, M.D. - Dana Farber Cancer Institute, Harvard Medical Professor of Medicine, Harvard Medical School, Chief Division of Blood Centers
This conference is open to the public, but directed primarily for medical oncologists and hematologists, as well as other healthcare professionals in the oncology field who are interested in the treatment of cancer. The conference will be held from 8 am to 2:30 pm in the Hekemian Conference Center Auditorium located at Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey. If you're interested in attending please contact David Marisol at 201-996-2515 or marisoldavid@humed.com.
Source: John Theurer Cancer Center
